pharmaceuticals « Science and Enterprise

Results from a large-scale clinical trial show almost the same health outcomes for patients prescribed high or low… https://t.co/cAg7Ygkv3I
about 19 hours ago
New post on Science and Enterprise: Trial Shows Same High/Low Dose Aspirin Outcomes https://t.co/N8mjm3cWX8 #Science #Business
about 19 hours ago
Venture funding for start-ups providing artificial intelligence services in health care climbed to a record high vo… https://t.co/FHzRPWsgKR
about 3 days ago
New post on Science and Enterprise: Infographic – Health Care A.I. Funds Jump in Q1 https://t.co/4L1DrqPRFT #Science #Business
about 3 days ago
This New York Times essay got here just in time ... Your Car, Toaster, Even Washing Machine, Can’t Work Without The… https://t.co/cuRLpV3PIT
about 3 days ago

Moderna Supplying 500M Vaccine Doses to Covax

By Alan, on May 3rd, 2021%

Moderna Inc. is providing up to 500 million doses of its Covid-19 vaccine to the Covax Facility, an international project distributing vaccines to low-income countries. . . . → Read More: Moderna Supplying 500M Vaccine Doses to Covax

Infographic – Covid-19 Vaccine Acceptance Gains Worldwide

By Alan, on April 24th, 2021%

Polling from across the world indicates that since the start of 2021, larger numbers of residents are vaccinated or plan to get vaccinated against the virus. . . . → Read More: Infographic – Covid-19 Vaccine Acceptance Gains Worldwide

Trial Shows Malaria Vaccine Protects Young Children

By Alan, on April 23rd, 2021%

Results from a clinical trial in Burkina Faso show a high efficacy rate for a candidate vaccine to protect young children against malaria infections. . . . → Read More: Trial Shows Malaria Vaccine Protects Young Children

Trials Adding Covid-19 Hospital, Out-Patient Therapies

By Alan, on April 22nd, 2021%

National Institutes of Health is adding a new treatment to a clinical trial for Covid-19 patients hospitalized with severe respiratory failure. . . . → Read More: Trials Adding Covid-19 Hospital, Out-Patient Therapies

Microbiome Health Company Raises $40M in Early Funds

By Alan, on April 21st, 2021%

A developer of therapies and health products addressing microbes inhabiting the human body is raising $40 million in its first venture funding round. . . . → Read More: Microbiome Health Company Raises $40M in Early Funds

Start-Up Designing Synthetic DNA for Gene Therapies

By Alan, on April 20th, 2021%

A new biotechnology company is underway creating gene therapies for inherited diseases delivered with synthetic DNA instead of benign viruses. . . . → Read More: Start-Up Designing Synthetic DNA for Gene Therapies

Challenge Trial Testing Covid-19 Reinfection

By Alan, on April 19th, 2021%

A clinical trial is underway testing immune responses from new Covid-19 infections in volunteers previously infected with the virus. . . . → Read More: Challenge Trial Testing Covid-19 Reinfection

Infographic – Israel Halts Covid-19 Spread with Vaccines

By Alan, on April 17th, 2021%

Israel is emerging as the world’s leader in vaccinating its population, and seeing results in declines of new Covid-19 cases. . . . → Read More: Infographic – Israel Halts Covid-19 Spread with Vaccines

Lilly Asks FDA to Revoke Covid-19 Therapy Clearance

By Alan, on April 16th, 2021%

Drug maker Eli Lilly and Co. asked the Food and Drug Administration to revoke its authorization for bamlanivimab alone to treat for Covid-19 infections. . . . → Read More: Lilly Asks FDA to Revoke Covid-19 Therapy Clearance

Novavax Joins Alternative Second Shot Vaccine Trial

By Alan, on April 15th, 2021%

Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in first and second immunizations. . . . → Read More: Novavax Joins Alternative Second Shot Vaccine Trial

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise